Navigation Links
Tragara Pharmaceuticals' Apricoxib Reverses EMT, a Key Process for Cancer Progression and Metastasis
Date:5/26/2011

catalytic product prostaglandin E2 (PGE2). Activation of the MAP kinase pathway by PGE2 induces the master regulators of EMT, the transcriptional repressors Snail and ZEB1 and also enhances TGFB-dependent EMT by blocking Smad signaling, suggesting that COX-2 derived PGE2 is a major driver of EMT in human cancer.

About Capoxigem® (apricoxib, TG01)

Capoxigem (apricoxib, TG01) is an oral, once-daily selective COX-2 inhibitor. It is being evaluated separately for the treatment of inflammation-related pain and cancer. In inflammation-related pain, Capoxigem modulates the cyclooxygenase pathway, reducing the production of inflammatory prostaglandins. A large phase IIa Proof-of-Concept and dose finding study in inflammation-related pain has been completed in the United States.  Superiority to placebo and an active comparator was demonstrated; safety was comparable to the active comparator.  

As an anti-cancer treatment, Capoxigem affects a number of different oncogenic signaling pathways, including the HIF-1, VEGF, VEGF-R and PDGF systems for angiogenesis; the EGFR, HER2/neu, Bcr/Abl for growth control and differentiation; the intrinsic and extrinsic pathways for apoptosis; and the integrin and metalloproteinase systems for tissue invasion and metastasis. Capoxigem also potently inhibits COX-2-derived PGE2 production, reversing the PGE2-dependent epithelial-mesenchymal transition (EMT) process and the associated progression and metastasis of solid tumors. In pre-clinical cancer models, Capoxigem has shown superiority to compounds with similar mechanisms of action and synergy in combination with cisplatin, trastuzumab, and pemetrexed.

Capoxigem added to erlotinib therapy in a clinically relevant subset of biomarker-selected patients with advanced refractory non-small cell lung cancer significantly prolonged time to progression, progression-free survival and overall survival in a phase II proof-of-concept study (APRiCOT-L).
'/>"/>

SOURCE Tragara Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 Perrigo Company plc (NYSE: ... Affordable Healthcare Products®," today announced that it has completed ... in a cash and equity transaction valued at approximately ... in debt. Sellers are Marc Coucke , Waterland ...   "The combination of Perrigo ...
(Date:3/30/2015)...  MedAptus® today announced the launch of Assign, ... needs for busy inpatient provider teams. Assign was ... to hospitalists or other rounding providers based on ... such as ensuring patient safety, proper reimbursement and ... In an increasingly risk-based healthcare ...
(Date:3/30/2015)... CHARLOTTE, N.C. , March 30, 2015 /PRNewswire/ ... today announced a worldwide search for product innovations ... The most promising ideas uncovered during the 8-week ... partners for potential commercialization.  Invention ideas can be ... www.EdisonNationMedical.com/Mobility now through May 28, 2015. ...
Breaking Medicine Technology:Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3
... December 6, 2011 Biospace Lab and the ... collaborating on the development of a new X-ray tomographic imaging ... a fully modular and versatile preclinical optical imager developed for ... new add-in module will be faster than current Micro CT ...
... 2011  Echo Therapeutics, Inc. (Nasdaq: ECTE ), ... non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and ... announced a registered direct equity financing of approximately $5.4 ... one share of its common stock and a warrant ...
Cached Medicine Technology:Biospace Lab Collaborates With ImaBio Group to Develop a Unique X-Ray Tomographic Module for its Preclinical Imaging System 2Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing 2Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing 3
(Date:3/30/2015)... March 30, 2015 Join local United ... Hike2Heal 5k to raise funds to provide healthcare for ... Uganda. Hike2Heal will take place on Saturday, April 18, ... No. 9 on 86 Vaughn Road in Nashville. , ... in an area without reliable medical care. The nearest ...
(Date:3/30/2015)... Good Shepherd Children’s Home announces 53rd year ... Murfreesboro provides a Christian-based home, the children learn biblical principles ... special plan for their life. , A day in ... as, one-by-one, the children begin to awake and prepare for ... continues to buzz. Sleepily, she crawls out of bed ...
(Date:3/30/2015)... March 31, 2015 Healtheminds, a start-up ... services through an innovative, easy to use and engaging ... create awareness about mental health related issues. The first ... to alcohol, tobacco and other drugs. , Consumption ... health effects. These include the toxic effects of excessive ...
(Date:3/30/2015)... City, Itah (PRWEB) March 30, 2015 ... insurance reimbursement for small businesses, announced its latest ... is available on webcast. This discussion was conducted ... , According to Zane Benefits, there is a ... small businesses. Instead of selecting a group health ...
(Date:3/30/2015)... Textile Exchange, a global nonprofit dedicated to sustainability ... latest version of its Responsible Down Standard (RDS) ... applied to any waterfowl-based supply chain to help ensure ... The goal of the RDS is to recognize and ... traceability so that products can be labeled accurately and ...
Breaking Medicine News(10 mins):Health News:Hike2Heal and Rethink Church Raise Funds To Provide Healthcare for Ugandan Children with 3rd Annual Raise the Roof 5K on April 18 2Health News:Good Shepherd Children’s Home Announces 53rd Year of Providing a Safe-Haven for Children in Need 2Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Zane Benefits New Webinar Premium Reimbursement Webinar Now Available On-Demand 2Health News:Responsible Down Standard 2.0 Released 2Health News:Responsible Down Standard 2.0 Released 3
... brain,s dopamine levels could point to more effective treatments ... -- Long-term changes in the brain,s dopamine-releasing machinery may ... say. , Dopamine is one of the brain,s major ... Bamford, of the University of Washington, Seattle, treated mice ...
... Skin Care and Frida,Kahlo Store are proud to announce the ... benefit of The Leukemia & Lymphoma Society. It,will take place ... Staten Island, New York, at 7:30 pm. This concert is ... with the solution,of health and social problems., The event ...
... leading global clinical,research organization, is pleased to announce that ... with CRO,s in Las Vegas, Nevada from April,14 to ... by,some of its executive team and employees. Chiltern will ... 2008 at 2:45 pm -- Track: Relationship Management ...
... to use iSEEK Medical Searchblade to optimize patient management ... ... 9 Physicians, nurses,physician assistants, pharmacists, and other clinicians searching for,medical ... Thanks to a new partnership between MedPage Today and iSEEK,the medical ...
... Peninsula Medical School, South West England, has found strong ... health of older people. , Two studies were conducted, ... Study of Ageing (ELSA). , The first study ... lived in urban areas across England. The study found ...
... April 9, 2008 Reflecting the,growing concern over ... in being able to afford a comfortable retirement,decreased ... in the 18 years of the,Retirement Confidence Survey(R)(RCS), ... of workers very confident about having enough money ...
Cached Medicine News:Health News:Researchers Define Mechanism of Methamphetamine Addiction 2Health News:Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CRO's Meeting in Las Vegas, April 14 - 16, 2008. 2Health News:MedPage Today(R) Selects iSEEK(TM) to Improve Quality of Patient Care 2Health News:MedPage Today(R) Selects iSEEK(TM) to Improve Quality of Patient Care 3Health News:MedPage Today(R) Selects iSEEK(TM) to Improve Quality of Patient Care 4Health News:Your neighborhood can affect your health 2Health News:18th Annual Retirement Confidence Survey:(R) Workers Show Record Drop in Retirement Confidence, Health Care and Economy Are Major Concerns 2Health News:18th Annual Retirement Confidence Survey:(R) Workers Show Record Drop in Retirement Confidence, Health Care and Economy Are Major Concerns 3Health News:18th Annual Retirement Confidence Survey:(R) Workers Show Record Drop in Retirement Confidence, Health Care and Economy Are Major Concerns 4
Swedish Knee Cage -- hinged to track knee motion. Effective control of genu recurvatum (back knee or knee hyperextension). Fits left or right....
... in the Cryo/Cuff line, the Knee Cryo/Cuff ... filled directly with water and ice eliminating ... the optimal amount of compression, a hand ... application. The cuff remains cold for about ...
... shoulder immobilization and ... motion for glenohumeral ... tears, and acromioclavicular ... brace is designed ...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: